Aquarius Surgical Technologies Inc.
ASTI
CNSX
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -65.82% | 53.63% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -65.82% | 53.63% | |||
| Cost of Revenue | -62.31% | 36.84% | |||
| Gross Profit | -68.97% | 72.62% | |||
| SG&A Expenses | 21.74% | 1.12% | |||
| Depreciation & Amortization | -3.70% | -5.26% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 12.02% | 3.60% | |||
| Operating Income | -33.64% | 4.99% | |||
| Income Before Tax | -7.55% | 0.19% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -7.55% | 0.19% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -7.55% | 0.19% | |||
| EBIT | -33.64% | 4.99% | |||
| EBITDA | -35.79% | 9.48% | |||
| EPS Basic | -6.78% | 0.00% | |||
| Normalized Basic EPS | -19.44% | 2.70% | |||
| EPS Diluted | -6.78% | 0.00% | |||
| Normalized Diluted EPS | -19.44% | 2.70% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
